Young James Emmett

Young James Emmett is listed in filings as Chief Financial Officer at TriSalus Life Sciences, Inc.. This profile follows SEC Form 4 activity through May 21, 2025, including purchase activity. Recent filings connect the profile to TriSalus Life Sciences, Inc. (TLSI). The current snapshot covers public activity from Jan 29, 2025 to May 21, 2025. Reported amounts are shown as $68.2K to $397.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.